These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9636394)

  • 1. Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):976-9. PubMed ID: 9636394
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1997 Dec; 29(8):3501-4. PubMed ID: 9414811
    [No Abstract]   [Full Text] [Related]  

  • 4. The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1997 Dec; 29(8):3497-500. PubMed ID: 9414810
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survival.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Dec; 30(8):4170-3. PubMed ID: 9865337
    [No Abstract]   [Full Text] [Related]  

  • 9. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
    Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
    Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific.
    Chong AS; Ma LL; Yin D; Blinder L; Shen J; Williams JW
    Xenotransplantation; 2000 Feb; 7(1):48-57. PubMed ID: 10809057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 14. Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
    Schorlemmer HU; Ruuth E; Kurrle R
    Transpl Int; 1998; 11 Suppl 1():S340-4. PubMed ID: 9665012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus.
    Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
    Transplant Proc; 1998 Dec; 30(8):4099-103. PubMed ID: 9865312
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model.
    Wijkström M; Song Z; Zhang J; Bari S; Sundberg B; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1024. PubMed ID: 10936331
    [No Abstract]   [Full Text] [Related]  

  • 17. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1999; 31(1-2):851-3. PubMed ID: 10083371
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection.
    Fukuzawa M; Okada A
    Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.